Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Healthcare Medical Devices
Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research... see more

Recent & Breaking News (TSXV:NSCI)

Nanalysis Announces Full Year 2023 Conference Call

PR Newswire 8 days ago

Nanalysis Scientific Corp. Announces Director Resignation

PR Newswire 9 days ago

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

PR Newswire April 4, 2024

NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT

Canada NewsWire March 20, 2024

Canadian Investment Regulatory Organization Trade Resumption - NSCI

Canada NewsWire March 6, 2024

Canadian Investment Regulatory Organization Trading Halt - NSCI

Canada NewsWire March 6, 2024

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

Canada NewsWire March 6, 2024

Nanalysis Announces Upcoming Webinar and Conference Participation

PR Newswire February 7, 2024

Nanalysis Achieves Record Revenue in Q4

PR Newswire February 6, 2024

Nanalysis Scientific Corp. Provides Update on Security Services Business

PR Newswire January 30, 2024

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

PR Newswire January 3, 2024

Nanalysis Reports Third Quarter 2023 Results

PR Newswire November 29, 2023

Nanalysis Announces Third Quarter 2023 Conference Call

PR Newswire November 15, 2023

Nanalysis to Present at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 & 1x1 Meetings on Thursday, September 7, 2023

PR Newswire August 30, 2023

Nanalysis Reports Second Quarter 2023 Results

PR Newswire August 24, 2023

Nanalysis Announces Second Quarter 2023 Conference Call

PR Newswire August 15, 2023

TSX Venture Exchange Stock Maintenance Bulletins

Canada NewsWire June 30, 2023

Nanalysis Enters into New Credit Facility with ATB Financial

PR Newswire June 29, 2023

Nanalysis To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar

PR Newswire June 20, 2023

Nanalysis Announces Annual General Meeting

PR Newswire June 15, 2023